Literature DB >> 2064486

Does racial variation in risk factors explain black-white differences in the incidence of hypertensive end-stage renal disease?

J C Whittle1, P K Whelton, A J Seidler, M J Klag.   

Abstract

Prospectively collected data on the incidence of treated hypertensive end-stage renal disease (HT-ESRD) were analyzed to investigate whether the higher rate of HT-ESRD in blacks compared with whites is due to differences in putative ESRD risk factors. The overall age-adjusted relative risks of HT-ESRD for black compared with white residents in the Maryland Regional ESRD Registry (Network 31) Catchment Area were 7.4 (95% confidence interval, 5.9 to 9.4) and 9.9 (95% confidence interval, 7.4 to 13.1) for men and women, respectively. In a population level analysis, race-specific HT-ESRD incidence rates in the black and white populations of 13 regions in Network 31 were related to the prevalence of putative ESRD risk factors in those populations. The latter were estimated from the 1981-1982 Maryland Statewide Household Hypertension Survey. Black populations had a 5.6-fold (95% confidence interval, 3.9 to 8.1) higher unadjusted incidence of HT-ESRD than white populations. The HT-ESRD incidence in a population was also directly related to that population's prevalence of hypertension, severe hypertension, and diabetes mellitus and inversely related to measures of socioeconomic status and mean age at diagnosis of hypertension. When adjusted simultaneously for age, prevalence of hypertension, severe hypertension, diabetes, and level of education, the risk of HT-ESRD was still 4.5 (95% confidence interval, 3.2 to 6.2) times higher for black compared with white populations. Our findings failed to support the hypothesis that race-related differences in the prevalence, severity, or age at onset of hypertension, in the prevalence of diabetes or in socioeconomic status, explain the well-recognized black-white differences in the HT-ESRD incidence.

Entities:  

Mesh:

Year:  1991        PMID: 2064486

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  34 in total

1.  Racial differences in the incidence of chronic kidney disease.

Authors:  Paul Muntner; Britt Newsome; Holly Kramer; Carmen A Peralta; Yongin Kim; David R Jacobs; Catarina I Kiefe; Cora E Lewis
Journal:  Clin J Am Soc Nephrol       Date:  2011-11-10       Impact factor: 8.237

2.  Racial differences in adherence to cardiac medications.

Authors:  Hyasmine Charles; Chester B Good; Barbara H Hanusa; Chung-Chou H Chang; Jeff Whittle
Journal:  J Natl Med Assoc       Date:  2003-01       Impact factor: 1.798

3.  Poverty and racial disparities in kidney disease: the REGARDS study.

Authors:  William M McClellan; Britt B Newsome; Leslie A McClure; George Howard; Nataliya Volkova; Paul Audhya; David G Warnock
Journal:  Am J Nephrol       Date:  2010-05-31       Impact factor: 3.754

4.  Racial differences in the association of pentraxin-3 with kidney dysfunction: the Multi-Ethnic Study of Atherosclerosis.

Authors:  Ruth Dubin; Michael Shlipak; Yongmei Li; Joachim Ix; Ian H de Boer; Nancy Jenny; Carmen A Peralta
Journal:  Nephrol Dial Transplant       Date:  2010-11-15       Impact factor: 5.992

5.  The need and demand for renal replacement therapy in ethnic minorities in England.

Authors:  P J Roderick; V S Raleigh; L Hallam; N P Mallick
Journal:  J Epidemiol Community Health       Date:  1996-06       Impact factor: 3.710

6.  Neighborhood poverty and racial differences in ESRD incidence.

Authors:  Nataliya Volkova; William McClellan; Mitchel Klein; Dana Flanders; David Kleinbaum; J Michael Soucie; Rodney Presley
Journal:  J Am Soc Nephrol       Date:  2007-12-05       Impact factor: 10.121

7.  Ethical considerations for conducting health disparities research in community health centers: a social-ecological perspective.

Authors:  Carla Boutin-Foster; Ebony Scott; Jennifer Melendez; Anna Rodriguez; Rosio Ramos; Balavenkatesh Kanna; Walid Michelen
Journal:  Am J Public Health       Date:  2013-10-17       Impact factor: 9.308

8.  African American kidney transplantation survival: the ability of immunosuppression to balance the inherent pre- and post-transplant risk factors.

Authors:  Gregory E Malat; Christine Culkin; Aniruddha Palya; Karthik Ranganna; Mysore S Anil Kumar
Journal:  Drugs       Date:  2009-10-22       Impact factor: 9.546

9.  Prevalence of mild impairment in renal function in a random sample of elders from a biethnic community survey.

Authors:  R D Lindeman; L J Romero; C L Yau; R N Baumgartner; P J Garry
Journal:  Int Urol Nephrol       Date:  2001       Impact factor: 2.370

10.  Null mutation of the nicotinamide adenine dinucleotide phosphate-oxidase subunit p67phox protects the Dahl-S rat from salt-induced reductions in medullary blood flow and glomerular filtration rate.

Authors:  Louise C Evans; Robert P Ryan; Elizabeth Broadway; Meredith M Skelton; Theresa Kurth; Allen W Cowley
Journal:  Hypertension       Date:  2014-12-08       Impact factor: 10.190

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.